Different role of endothelium/nitric oxide in 17β-estradiol- and progesterone-induced relaxation in rat arteries

被引:20
作者
Chan, HY
Yao, XQ
Tsang, SY
Chan, FL
Lau, CW
Huang, Y [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Physiol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Anat, Shatin, Hong Kong, Peoples R China
关键词
17; beta-estradiol; progesterone; nitric oxide; vaosdilation; endothelium; arteries;
D O I
10.1016/S0024-3205(01)01235-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study was aimed to examine the different role of endothelium/nitric oxide in relaxation induced by two female sex hormones, 17 beta -estradiol and progesterone in rat isolated aortas and mesenteric arteries. The isometric force of each ring was measured with Grass force-displacement transducers in the organ bathes. 17 beta -Estradiol induced both endothelium-dependent and -independent relaxation in the rat aortas but only the endothelium-independent relaxation in the rat mesenteric arteries. In contrast, progesterone induced both endothelium-dependent and -independent relaxation in the rat mesenteric arteries but only endothelium-independent relaxation in rat aortas. N-G-Nitro-L-arginine methyl ester and methylene blue attenuated the relaxant response to 17 beta -estradiol in the aortic rings or to progesterone in the mesenteric arteries. Pretreatment with L-arginine antagonized the effect of Nc-nitro-L-arginine methyl ester on sex hormone-induced relaxation. The endothelium contribution to relaxation seems to only relate to lower concentrations of 17 beta -estradiol and progesterone. In summary, the present results clearly demonstrate a different role of the functional endothelium in the relaxant response to 17 beta -estradiol or progesterone in the conduit vessel (aorta) and the resistance vessels (mesenteric artery). Nitric oxide contributes largely to the endothelium-dependent relaxation induced by 17 beta -estradiol in the isolated aortas or by progesterone in the mesenteric arteries. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1609 / 1617
页数:9
相关论文
共 20 条
[1]   17β-estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS [J].
Binko, J ;
Majewski, H .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (03) :H853-H859
[2]   N(G)-NITRO L-ARGININE METHYL-ESTER AND OTHER ALKYL ESTERS OF ARGININE ARE MUSCARINIC RECEPTOR ANTAGONISTS [J].
BUXTON, ILO ;
CHEEK, DJ ;
ECKMAN, D ;
WESTFALL, DP ;
SANDERS, KM ;
KEEF, KD .
CIRCULATION RESEARCH, 1993, 72 (02) :387-395
[3]   17β-estradiol stimulates flow-induced vasodilatation in isolated small mesenteric arteries from prepubertal female rats [J].
Cockell, AP ;
Poston, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (06) :1432-1438
[4]   Non-genomic effects of estrogen and the vessel wall [J].
Farhat, MY ;
AbiYounes, S ;
Ramwell, PW .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (05) :571-576
[5]   Estrogen replacement increases beta-adrenoceptor-mediated relaxation of rat mesenteric arteries [J].
Ferrer, M ;
Meyer, M ;
Osol, G .
JOURNAL OF VASCULAR RESEARCH, 1996, 33 (02) :124-131
[6]   Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women [J].
Gerhard, M ;
Walsh, BW ;
Tawakol, A ;
Haley, EA ;
Creager, SJ ;
Seely, EW ;
Ganz, P ;
Creager, MA .
CIRCULATION, 1998, 98 (12) :1158-1163
[7]   EFFECTS OF PHYSIOLOGICAL LEVELS OF ESTROGEN ON CORONARY VASOMOTOR FUNCTION IN POSTMENOPAUSAL WOMEN [J].
GILLIGAN, DM ;
QUYYUMI, AA ;
CANNON, RO ;
JOHNSON, GB ;
SCHENKE, WH .
CIRCULATION, 1994, 89 (06) :2545-2551
[8]   PROGESTERONE INDUCES ENDOTHELIUM-INDEPENDENT RELAXATION OF RABBIT CORONARY-ARTERY INVITRO [J].
JIANG, CW ;
SARREL, PM ;
LINDSAY, DC ;
POOLEWILSON, PA ;
COLLINS, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 211 (02) :163-167
[9]   ENDOTHELIUM-INDEPENDENT RELAXATION OF RABBIT CORONARY-ARTERY BY 17-BETA-ESTRADIOL INVITRO [J].
JIANG, CW ;
SARREL, PM ;
LINDSAY, DC ;
POOLEWILSON, PA ;
COLLINS, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (04) :1033-1037
[10]  
Ma LM, 1997, J CARDIOVASC PHARM, V30, P130